Abstract
The present application provides immune cells comprising an HPV antigen and an adjuvant, methods of manufacturing such modified immune cells, and methods of using such modified immune cells for treating an HPV-associated disease, preventing an HPV-associated disease and/or for modulating an immune response in an individual with an HPV-associated disease.
Full Text
What is claimed is:
The present application provides immune cells comprising an HPV antigen and an adjuvant, methods of manufacturing such modified immune cells, and methods of using such modified immune cells for treating an HPV-associated disease, preventing an HPV-associated disease and/or for modulating an immune response in an individual with an HPV-associated disease.
Timeline
Filed
03/16/2026Published
07/02/2026Granted
Not AvailableIPC Codes(11)
A61K 39/12:Viral antigens
A61K 33/243:Platinum; Compounds thereof
A61K 39/00:Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N 33/53)